Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Levothyroxine effectively treated a dog's skin and hair problems caused by hypothyroidism.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

New cytokine-targeted therapies show promise for treating alopecia areata.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

Anti-SSB antibodies are useful for diagnosing systemic lupus erythematosus and are linked to specific symptoms.

Genetic testing is crucial before giving azathioprine to avoid severe side effects.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Ruxolitinib treatment may cause eyelash growth.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The document emphasizes the importance of correctly identifying and classifying genetic hair disorders to help diagnose related health conditions.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

The document explains how to identify different hair problems using a microscope.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Using old drugs for new uses can help treat rare immune deficiencies.